Table 6

Comparison of sites of disease and laboratory findings between the present series and those of Ferreri et al20 

Present seriesFerreri et al20 P
No. of patients 96 38 — 
B symptoms, % 76 55 .018 
Sites of disease, % 
    Bone marrow 75 32 < .001 
    Spleen 67 26 < .001 
    Liver 55 26 .003 
    Peripheral blood 24 5 .012 
    Central nervous system 27 39 .171 
    Skin 15 39 .002 
    Lymph nodes 11 11 > .999 
Laboratory findings, % 
    Anemia, less than 120 g/L hemoglobin* 78 63 .075 
    Thrombocytopenia, less than 150 × 109/L 76 29 < .001 
    Serum LDH level, high† 93 86 .278 
    Hypoalbuminemia: less than 36 g/L 84 18 < .001 
Present seriesFerreri et al20 P
No. of patients 96 38 — 
B symptoms, % 76 55 .018 
Sites of disease, % 
    Bone marrow 75 32 < .001 
    Spleen 67 26 < .001 
    Liver 55 26 .003 
    Peripheral blood 24 5 .012 
    Central nervous system 27 39 .171 
    Skin 15 39 .002 
    Lymph nodes 11 11 > .999 
Laboratory findings, % 
    Anemia, less than 120 g/L hemoglobin* 78 63 .075 
    Thrombocytopenia, less than 150 × 109/L 76 29 < .001 
    Serum LDH level, high† 93 86 .278 
    Hypoalbuminemia: less than 36 g/L 84 18 < .001 

— indicates not applicable.

*

Values for this term are based on the definition by Ferreri et al.20 

†

Higher than the upper limit of the standard range defined by each institution.

View Large